Immuno¢xation (IFX) on serum has been recommended in two kinds of settings: ¢rst, where highresolution electrophoresis (HRE) shows an abnormal band and there is therefore a need to con¢rm its monoclonal nature; and second, where an abnormal band is not obvious. 1^3 In the latter situation, it is a strong clinical suspicion of a monoclonal gammopathy, rather than an abnormal HRE pattern, that dictates the need for IFX. 1^3 Heavy-chain disease and IgD or IgE myeloma are examples of this category. 4^7 Light-chain myeloma (LCM), with its characteristic hypogammaglobulinaemia, absence of abnormal band on serum electrophoresis and light-chain proteinuria, does not quite ¢t into either category. In this disease, except in the uncommon event of polymerization of light chains or renal impairment, it is unusual to see an abnormal band on HRE of serum. 8 However, unlike other clinical settings in which a monoclonal gammopathy is investigated despite the absence of an abnormal serum band, a suspicion of LCM based on clinical features and hypogammaglobulinaemia does not lead one to perform IFX on serum. Instead, IFX is performed on the urine because urine shows abnormal band(s). Since the diagnosis is easily made in this manner, IFX on the serum is not carried out, even though it is obvious that light chains must be present in the serum in order for them to appear in the urine. The present investigation was carried out to assess whether, in LCM, IFX would pick up these serum monoclonal light chains that are too small in quantity to show up either on HRE or on densitometric scan.
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Immuno¢xation was performed on the serum samples of two cases of LCM, in which HRE had shown hypogammaglobulinaemia but no abnormal band and in which the b and a globulin bands were densitometrically in the reference range. High-resolution electrophoresis using agarose and IFX were carried out by standard techniques. 9 In spite of the absence of any suggestion of an abnormal band on electrophoresis or densitometry, IFX showed a very distinct monoclonal band in both cases in the b zone (see Fig. 1 ). The bands were k and l respectively in the two cases.
Our study thus showed that IFX is able to clearly and prominently demonstrate a monoclonal light chain band in the b globulin position in LCM, in a setting of reduced g globulins and an otherwise normal electrophoretic and densitometric result. This small study thus con¢rms the recently reported sensitivity and usefulness of IFX, 7 and clari¢es why IFX has been recommended in follow-up studies in multiple myeloma cases post-transplant. 7 The ¢ndings of our study also imply that a de¢nitive diagnosis of LCM based on demonstration of an M band is possible on the examination of serum alone. This, of course, is not to say that an abnormal band should not be sought in the urine in myeloma. However, our ¢nding may be of relevance for those laboratories, particularly in third world countries, which, because of ¢nancial constraints, are unable to perform the more costly urine electrophoresis as a ¢rst-line investigation along with serum electrophoresis in cases of suspected myeloma. 
Electrophoresis of the corresponding serum (P) and a normal control serum sample (N) (lanes 7 and 8, respectively) showed hypogammaglobulinaemia but no abnormal band in the patient's sample. Testicular germ cell tumour presenting as thyrotoxicosis I read with interest the case report 'Testicular germ cell tumour presenting as thyrotoxicosis' 1 in this journal. The article is a timely reminder for laboratarians and clinicians about the myriad of thyrotoxic causes. Additional comments are warranted, however. The basis for diagnosing any medical condition remains that of a thorough history, with a high index of suspicion, and clinical examination. The latter would have undoubtedly picked up the tumour size and site. It is perplexing that the patient is not aware of his 9 cm testicular size. This is equivalent to, if not larger than, the size of a tennis ball. It is true however that 'the genitalia remain the graveyard of the diagnostically inept'.
There is no doubt that the patient is clinically thyrotoxic. When the patient has not improved, a review of the diagnosis is mandatory. Additional investigations, including elevated free tri-iodothyronine level, a positive thyroid 99m technetiump ertechnetate uptake scan and negative auto-immune thyroid auto-antibody study, should assist in further delineating the diagnosis. 2 The pathophysiology of human chorionic gonadotropin (hCG)-mediated thyrotoxicosis is the excess synthesis and subsequent release of thyroid hormones due to overwhelming thyrotropin (TSH)-receptor binding. Thus the thioamides, which act by blocking thyroid hormone synthesis, should work providing adequate dosage is used. Carbimazole of up to 60 mg daily has been used in similar situation. 3,4 Also, extreme caution should be applied to the use of non-speci¢c beta-blockade drugs such as propranolol in the presence of worsening breathlessness, even in the absence of known and existing bronchospasm.
It is the b-subunits of hCG and TSH that share structural homology. There is 85% sequence homology in the ¢rst 114 amino acid sequence and 12 cysteine residues in the b-subunits. The a-subunit of HCG is identical to other pituitary glycoprotein hormones. 5 It has been estimated that for every 10 000 IU/L hCG increase, there is 0.6 pmol/L increase in free tetraiodothyronine (fT4) and a 0.1mIU/L decrease in TSH concentrations. 6 The impression given that tumour markers (TMs) are used in an attempt to localize the site of the primary tumour should be dispelled. b-HCG is probably the only TM where high levels can assist in the diagnosis^but only in the right clinical context. 7 Generally, TMs should remain a prognostic indicator and a monitoring tool in response to treatment.
It is not de¢nitive that the patient dies from pulmonary-embolus related cause (tumour or thrombosis). It is critical that patients of this age group who die acutely of uncertain causes undergo a complete and thorough post-mortem examination. Understandably, the post-mortem is probably a limited one in this case. Such practice may give credence to family screening given that a proportion of germ cell tumours are hereditary in nature. 8 An alternative to the above hypothetical cause of death is hyperthyroidism related heart failure exacerbating unrecognized ischaemic or hypertensive heart disease. 9 Thyroid storm is another consideration and is consistent with the clinical state. Death due to cardiac arrhythmia is unlikely as the frequency of ventricular asystole or arrhythmia in thyrotoxosis is similar to that of the general population. This lends support to the theory of probable coexisting coronary cardiac disease. Thyroid excess may also elicit potassium disturbance further aggravating cardiac arrhythmia albeit in genetically predisposed individuals. 11
